Scientists have solved the mystery of how two opposite methods of targeting the same brain receptor can both lead to weight loss. The research focused on the GIP receptor and its varying effects depending on the location within the brain.
In studies involving mice, researchers found that activating the GIP receptor in the brainstem resulted in reduced appetite. Conversely, blocking the same receptor in the hypothalamus removed a "brake" on fullness signals, which also promoted weight loss.
This discovery explains why different obesity drugs can achieve similar results despite using opposite mechanisms. The findings suggest that combining GIP-targeting treatments with GLP-1 drugs, such as those related to Ozempic and Wegovy, could be an effective approach to treatment.
We don't rate truth. We strip the spin and show you which perspectives covered the story. You decide.
Read the original coverage
💬 Comments
📜 Comment Policy